5:35 PM
 | 
Dec 07, 2012
 |  BC Extra  |  Company News

FDA to discuss J&J's canagliflozin

FDA's Endocrinologic and Metabolic Drugs Advisory Committee will meet on Jan. 10, 2013, to discuss an NDA from...

Read the full 67 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >